<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijms-21-05559-t001" orientation="portrait" position="float">
 <object-id pub-id-type="pii">ijms-21-05559-t001_Table 1</object-id>
 <label>Table 1</label>
 <caption>
  <p>List of available drugs targeting SARS-CoV-2 infection and their effective dosage.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name of Medicine</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Target</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Effective Dosage</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Registered Clinical Trial</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Remdesivir</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viral RNA polymerase</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-viral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IV injection 200 mg at day first, 100 mg for 9 days</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04257656, NCT04252664, NCT04292730, NCT04315948, NCT04321616</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B237-ijms-21-05559" ref-type="bibr">237</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lopinavir/Ritonavir</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viral protease</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-viral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral administration 400 mg lopinavir and 100 mg ritonavir twice a day for 14 days, peroral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ACTRN12620000445976, NCT02735707, ISRCTN83971151, NCT04321174, NCT04350684, ISRCTN50189673, NCT04315948, NCT04328012, NCT04276688, ISRCTN50189673, NCT04321993</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B114-ijms-21-05559" ref-type="bibr">114</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Favipiravir</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viral RdRP </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-viral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral administration 1600 mg twice daily on first day and 600 mg twice a day on day 2−14.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2020-001435-27, NCT04359615, NCT04303299, NCT04402203</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B120-ijms-21-05559" ref-type="bibr">120</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ribavirin </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">viral RNA </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-viral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500 mg each time, 2 to 3 times/day in combination with IFN-α or lopinavir/ritonavir </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04276688, NCT04392427, ChiCTR2000029387</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B238-ijms-21-05559" ref-type="bibr">238</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arbidol </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viral RNA polymerase</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-viral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">200 mg three times a day for a duration of 7–14 days</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04260594, NCT04350684, NCT04255017</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B239-ijms-21-05559" ref-type="bibr">239</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Camostat </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TMPRSS2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-viral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">600 mg (200 mg, three times)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04353284</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B240-ijms-21-05559" ref-type="bibr">240</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nafamostat </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TMPRSS2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-viral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">240 mg daily, for 5 days, peroral</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04418128</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B138-ijms-21-05559" ref-type="bibr">138</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chloroquine Phosphate </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ACE2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-parasite</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500 mg (300 mg for chloroquine) each time, 2 times/day</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04303507, NCT04324463, NCT04353336, NCT04328493</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B238-ijms-21-05559" ref-type="bibr">238</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hydroxychloroquine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endosome, pH elevation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-parasite</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">200 mg, three times per day for ten days</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04261517, NCT04308668, NCT02735707, ISRCTN83971151, NCT04315948, NCT04321616, NCT04350684</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B158-ijms-21-05559" ref-type="bibr">158</xref>,
     <xref rid="B239-ijms-21-05559" ref-type="bibr">239</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IVIG</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">immune modulation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Immunoglobulin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">400 mg/kg for a duration of five days in children</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04411667, NCT04261426</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B241-ijms-21-05559" ref-type="bibr">241</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ivermectin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of nuclear transport</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-parasite</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oral administration 600 μg/kg) daily for 3 days </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04343092, NCT04392427</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B242-ijms-21-05559" ref-type="bibr">242</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tocilizumab</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-6 receptor subunit alpha</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Monoclonal antibody</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">400 mg intravenous or 8 mg/kg × 1–2 doses. Second dose 8–12 h after first dose if inadequate response.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04335071, ChiCTR2000030894</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B239-ijms-21-05559" ref-type="bibr">239</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Azitromycin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23S rRNA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-microbial</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">500 mg on day 1 followed by 250 mg/day for the next four days (in combination with hydroxychloroquine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04359316, NCT04332107, NCT04336332, NCT04329832</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B158-ijms-21-05559" ref-type="bibr">158</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Corticosteroides</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Binds glucocorticoid receptor and suppress inflammation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-Inflammation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 mg methylprednisolone once or twice daily</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04273321</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B226-ijms-21-05559" ref-type="bibr">226</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dexamethasone</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Binds glucocorticoid receptor and suppress inflammation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-Inflammation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 milligrams/day for 10 days</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ISRCTN50189673, NCT04381936</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B243-ijms-21-05559" ref-type="bibr">243</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nitricoxide</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activates cGMP </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">vasodilator</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">For SARS patients; Inhalation for ≥3 days (30 ppm on day 1, 20 and 10 ppm on days 2 &amp; 3)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NCT04383002, NCT04338828, NCT04358588, NCT04305457</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B236-ijms-21-05559" ref-type="bibr">236</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>TMPRSS2, transmembrane protease serine 2; ACE2, angiotensin converting enzyme II, IFN-α, interferon-α.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
